Table 1.
Clinical characteristics of patients
| Characteristics | n = 2984 | |
|---|---|---|
| Sex | Male | 1584 (53.1%) |
| Female | 1400 (46.9%) | |
| Age (years) | 20–29 | 1 (0.0%) |
| 30–39 | 24 (0.8%) | |
| 40–49 | 165 (5.5%) | |
| 50–59 | 530 (17.8%) | |
| 60–69 | 1038 (34.8%) | |
| 70–79 | 1024 (34.3%) | |
| 80–89 | 195 (6.5%) | |
| >90 | 7 (0.2%) | |
| Mean ± SD | 66.1 ± 10.1 | |
| Cause of liver cirrhosis | HBV | 217 (7.3%) |
| HCV | 1755 (58.8%) | |
| Alcohol | 487 (16.3%) | |
| PBC | 74 (2.5%) | |
| AIH | 63 (2.1%) | |
| HBV + HCV | 16 (0.5%) | |
| HBV + alcohol | 29 (1.0%) | |
| HCV + alcohol | 92 (3.1%) | |
| HBV + HCV + alcohol | 2 (0.1%) | |
| Other | 57 (1.9%) | |
| Unknown | 192 (6.4%) | |
| Treatment adherence (during 6 months) | All | 2545 (85.3%) |
| Half or less | 439 (14.7%) | |
| Previous hepatic cancer | Yes | 504 (16.9%) |
| No | 2454 (82.2%) | |
| Unknown | 26 (0.9%) | |
| Current clinical manifestations | Yes | 1568 (52.6%) |
| No | 1410 (47.3%) | |
| Unknown | 6 (0.2%) | |
| Previous clinical manifestations | Yes | 1291 (43.3%) |
| No | 1670 (56.0%) | |
| Unknown | 23 (0.8%) | |
| Diabetes | Yes | 536 (18.0%) |
| No | 2448 (82.0%) | |
| Serum albumin (g/dL) | 3.04 ± 0.36 | |
| Platelet (×10 000/μL) | 9.73 ± 6.15 | |
| AST (IU/L) | 67.1 ± 62.8 | |
| ALT (IU/L) | 47.8 ± 40.9 | |
| Serum total bilirubin (mg/dL) | 1.30 ± 0.62 | |
| BTR | 2.95 ± 1.37 |
For categorical variables, the number of patients and percentage are shown. For continuous variables, the mean ± SD is presented.
AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BTR, branched-chain amino acid/tyrosine ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; SD, standard deviation.